Related content

Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer - a phase II study

By Pectasides D.   Visvikis A.   Kouloubinis A.   Glotsos J.   Bountouroglou N.   Karvounis N.   Ziras N.   Athanassiou A.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1194-1200

Elsevier

Access to resources Recommend Favorite

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

By Kallab Andre   Nalamolu Yasolatha   Dainer Paul   Jillella Anand  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 145-151

Humana Press, Inc

Access to resources Recommend Favorite

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

By Wang Lin   Huang Ming   Zhang Guo   Xu Nong   Wu Xiu  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 601-607

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

By Tsunoda Toshiyuki   Koizumi Tomonobu   Hayasaka Muneharu   Hirai Kazuya   Koyama Shigeru   Takabayashi Yasuki   Fujimoto Keisaku   Kubo Keishi  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 173-177

Springer Publishing Company

Access to resources Recommend Favorite

A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)

By Raez Luis   Santos Edgardo   Webb R.   Wade James   Brito Roger   Karr Melissa   Kennah Andra   Childs Barrett  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1103-1110

Springer Publishing Company

Access to resources Recommend Favorite